Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study
Open Access
- 27 December 2007
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 5 (1) , 70
Abstract
To assess the impact of polymorphisms in Glutathione S-transferase (GST) -P1, -M1, and -T1 on self-reported chemotherapy-induced long-term toxicities in testicular cancer survivors (TCSs).Keywords
This publication has 43 references indexed in Scilit:
- Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer SurvivorsJournal of Clinical Oncology, 2007
- Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based ChemotherapyClinical Cancer Research, 2006
- Paternity Following Treatment for Testicular CancerJNCI: Journal of the National Cancer Institute, 2005
- GLUTATHIONE TRANSFERASESAnnual Review of Pharmacology and Toxicology, 2005
- Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's LymphomaClinical Cancer Research, 2005
- Possible Mechanism Responsible for the Acquisition of Resistance to Cis-Diamminedichloroplatinum (II) by Cultured Human Testicular Seminoma CellsJournal of Urology, 2004
- Long-term sequelae after cancer therapyActa Oncologica, 2004
- Tinnitus in the Older AdultDrugs & Aging, 2004
- Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage ISupportive Care in Cancer, 1996
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987